The Effects of Chronic Exposure to Low-Level Blasts
NCT01524822 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 66
Last updated 2023-03-17
Summary
Background:
\- Repeated exposure to explosions may lead to changes in the way that people think or feel. Breachers (people trained to use explosives to get into buildings) are exposed to repeated blasts as part of their job. Researchers want to study how they might be affected by blast exposure. Breachers will be compared with other groups who have different levels of exposure to repeated blasts. Information will also be obtained from spouses or close companions.
Objectives:
\- To study the effects of repeated exposure to low-level blasts on thinking, memory, behavior, and brain function.
Eligibility:
* Experienced military and civilian breachers, experienced active duty artillery operators, and active duty military without frequent blast exposure, 18 and 60 years of age.
* Spouses or close companions of these individuals.
Design:
* Participants will be screened with a physical exam and medical history. Blood samples will be collected and a urine pregnancy test will be required of participants (not companions) before MRI scanning.
* Participants will spend up to 5-days as a NIH clinic outpatient, with about 6 hours of tests each day. Tests will include the following:
* Medical and professional history, with questions about exposures to blasts
* Tests of thinking, memory, and concentration
* Balance tests
* Hearing tests
* Imaging studies, such as magnetic resonance imaging, to look at the brain
* Overnight sleep study to monitor brain waves
* Blood samples
* Participants will return 1 year later for a 3-day followup visit. Some of the tests from before will be repeated. A spouse or close companion (if available) will be asked to complete questionnaires or have a telephone interview....
Conditions
- Tramatic Brain Injury
Sponsors & Collaborators
-
Walter Reed Army Institute of Research (WRAIR)
collaborator FED -
Naval Medical Research Center
collaborator FED -
National Institute of Neurological Disorders and Stroke (NINDS)
lead NIH
Principal Investigators
-
Eric M Wassermann, M.D. · National Institute of Neurological Disorders and Stroke (NINDS)
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-07-30
Countries
- United States
Study Locations
More Related Trials
-
Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)
NCT04124029 ·Status: RECRUITING
-
Developing and Validating Blood and Imaging BIOmarkers of AXonal Injury Following Traumatic Brain Injury
NCT03534154 ·Status: COMPLETED
-
Cerebrovascular Reactivity and Oxygen Metabolism as Markers of Neurodegeneration After Traumatic Brain Injury
NCT04820881 ·Status: UNKNOWN
-
Vietnam Head Injury Study - Phase III
NCT00132249 ·Status: COMPLETED
-
PET Whole Body Imaging Using a Peripheral Benzodiazepine Receptor Ligand [C-11]PBR28
NCT00407693 ·Status: COMPLETED ·Phase: PHASE1
-
Imaging Dopamine Function and Its Impact on Outcome After Traumatic Brain Injury (TBI)
NCT01850290 ·Status: COMPLETED
-
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
NCT01886820 ·Status: UNKNOWN ·Phase: PHASE3
-
Prazosin and Cerebrospinal Fluid (CSF) Biomarkers in Mild Traumatic Brain Injury (mTBI)
NCT03221751 ·Status: TERMINATED ·Phase: PHASE4
-
Prediction of Secondary Neurological Deterioration in Patients With Moderate Traumatic Brain Injury
NCT04854954 ·Status: COMPLETED
-
Deployment Related Mild Traumatic Brain Injury (mTBI)
NCT01847040 ·Status: COMPLETED
-
Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Precision Medicine Phase 2 Option 1
NCT04602806 ·Status: ACTIVE_NOT_RECRUITING
-
Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias
NCT04786223 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Real Time Vital Sign Assessment to Predict Neurological Decline After Traumatic Brain Injury
NCT05084352 ·Status: RECRUITING
-
Risk Assessment of Mild Traumatic Brain Injury in Military Training
NCT06992570 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Imaging [18F]PI-2620 and [18F]Florbetaben in Military Service Members With Blast Related Mild Traumatic Brain Injury
NCT05337774 ·Status: TERMINATED ·Phase: PHASE1
-
Advanced MRI In Acute Military TBI
NCT01313130 ·Status: UNKNOWN
-
PET Imaging of Nicotinic Acetylcholine Receptors
NCT01046513 ·Status: COMPLETED
-
Brain Injury Biomarkers in the General Population
NCT01786460 ·Status: COMPLETED
-
Transforming Research and Clinical Knowledge in Traumatic Brain Injury
NCT02119182 ·Status: COMPLETED
-
Acute and Mild TBI Injury in Military and Civilian Population Using Advanced MR Imaging
NCT05101239 ·Status: ACTIVE_NOT_RECRUITING
-
Beta-Amyloid Imaging With [18F]NAV4694 PET in Predicting Progression to AD in Subjects MCI
NCT01812213 ·Status: TERMINATED ·Phase: PHASE2
-
An Open Positron Emission Tomography Study to Assess the Effects of Varying Mass of AZD4694 on Radioligand Binding Parameters in Healthy Volunteers and Patients With Alzheimer's Disease
NCT01325402 ·Status: COMPLETED ·Phase: PHASE1
-
Long-term Follow-up in Severe Traumatic Brain Injury
NCT05235802 ·Status: UNKNOWN
-
Amantadine and Functional Improvement Following ABI Measured by MRI Tractography; A Pilot Study
NCT02566720 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of the PET Imaging Agent [18F]NAV4694 in Subjects With Probable Alzheimer's Disease
NCT01680588 ·Status: UNKNOWN ·Phase: PHASE2